Adaptive Biotechnologies (NASDAQ:ADPT) Chief Financial Officer Kyle Piskel sold 18,672 shares of the company’s common stock on March 11, 2026, at a price of $13.17, for a total transaction value of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results